Question 82

Dutasteride is indicated to treat symptoms associated with benign prostatic hyperplasia.

Dutasteride is primarily used to treat symptoms related to benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate that can lead to urinary difficulties.

A) generalized-onset seizures.

Generalized-onset seizures are a type of seizure that affects both sides of the brain and are typically treated with anticonvulsant medications. Dutasteride does not have any indication for seizure management, making this option incorrect.

B) Parkinson's disease.

Parkinson's disease is a neurodegenerative disorder that affects movement and is treated with medications such as levodopa and dopamine agonists. Dutasteride does not relate to Parkinson's disease treatment, thus this option is also incorrect.

C) benign prostatic hyperplasia.

Dutasteride is specifically indicated for the treatment of benign prostatic hyperplasia, as it helps to reduce the size of the prostate and alleviate urinary symptoms associated with this condition. This makes option C the correct choice.

D) rheumatoid arthritis.

Rheumatoid arthritis is an autoimmune disorder that affects the joints and is typically treated with anti-inflammatory drugs and disease-modifying antirheumatic drugs (DMARDs). Dutasteride does not have any approved use for rheumatoid arthritis, rendering this option incorrect.

Conclusion

Dutasteride is unequivocally indicated for the treatment of benign prostatic hyperplasia, as it directly addresses the symptoms associated with this condition. The other options do not relate to the therapeutic use of dutasteride, confirming that they are incorrect in this context.